Introduction:
Accuracy of point-of-care (POC) glucose devices compared to central lab values in critically ill patients has come into question, particularly during intensive insulin therapy.
POC devices perform particularly poorly in the hypoglycemic range.
Typically tested under ideal conditions in the lab; intraoperative, real-life data are lacking
